2022. Antisense Oligonucleotide Therapy for an Ultra-Rare Neurological Variant: A Case Report. Translational Medicine & Therapeutics Journal. 1, 1 (May 2022), 37–45. DOI:https://doi.org/10.5281/zenodo.22648851.